title: Use of urokinase in acute myocardial infarction.
abstract: In a prospective study 88 patients with acute MI were treated with urokinase. In comparison to a control group without thrombolytic therapy 50% of the urokinase treated patients showed an improvement as well of coronary sinus blood flow as of parameters of QRST mapping.
authors: First Medical Institute (Setchenow), Moscow, USSR.
authors: V I
authors: VI
authors: Makolkin
authors: I N
authors: IN
authors: Bokarew
authors: V N
authors: VN
authors: Buturow
authors: V N
authors: VN
authors: Terechow
authors: V A
authors: VA
authors: Kuznetzow
authors: M V
authors: MV
authors: Seryogina
authors: L D
authors: LD
authors: Yarowaya
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D011446:Prospective Studies; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014568:Urokinase-Type Plasminogen Activator